Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro

Bone

Volumn 44, Issue 4, 2009, Pages 717-728

  Morko, Jukka ^a   Kiviranta, Riku ^a   Mulari, Mika T K ^b   Ivaska, Kaisa K ^b   Väänänen, H Kalervo ^b   Vuorio, Eero ^a   Laitala Leinonen, Tiina ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b Institute of Biomedicine   (Finland)

Author keywords

Bone resorption; Cathepsin K; Osteoclast; Overexpression; Rodent

Indexed keywords

CATHEPSIN K;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE MARROW; CELL DIFFERENTIATION; CELL ISOLATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORTICAL BONE; CYTOPLASM; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; GENE LOCUS; HEMATOPOIETIC CELL; MESENCHYME CELL; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSGENE;

ANIMALS; BLOTTING, WESTERN; BONE RESORPTION; CATHEPSINS; CELL DIFFERENTIATION; FLUORESCENT ANTIBODY TECHNIQUE; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; OSTEOBLASTS; OSTEOCLASTS; PROTEIN TRANSPORT;

EID: 61749097288     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.11.019     Document Type: Article

References (89)

1. Takahashi N., Udagawa N., Takami M., and Suda T. Cells of bone: osteoclast generation. In: Bilezikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principles of bone biology, vol. 1 (2002), Academic Press, San Diego, California, USA 109-126
2. Väänänen H.K., and Laitala-Leinonen T. Osteoclast lineage and function. Arch. Biochem. Biophys. 473 (2008) 132-138
3. Boyce B.F., Yoneda T., Lowe C., Soriano P., and Mundy G.R. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. 90 (1992) 1622-1627
4. Saftig P., Hunziker E., Wehmeyer O., Jones S., Boyde A., Rommerskirch W., et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13453-13458
5. Dougall W.C., Glaccum M., Charrier K., Rohrbach K., Brasel K., De Smedt T., et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 13 (1999) 2412-2424
6. Gowen M., Lazner F., Dodds R., Kapadia R., Feild J., Tavaria M., et al. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J. Bone Miner. Res. 14 (1999) 1654-1663
7. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397 (1999) 315-323
8. Li Y.P., Chen W., Liang Y., Li E., and Stashenko P. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat. Genet. 23 (1999) 447-451
9. Chellaiah M., Kizer N., Silva M., Alvarez U., Kwiatkowski D., and Hruska K.A. Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength. J. Cell Biol. 148 (2000) 665-678
10. Feng X., Novack D.V., Faccio R., Ory D.S., Aya K., Boyer M.I., et al. A Glanzmann's mutation in beta 3 integrin specifically impairs osteoclast function. J. Clin. Invest. 107 (2001) 1137-1144
11. Kornak U., Kasper D., Bosl M.R., Kaiser E., Schweizer M., Schulz A., et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104 (2001) 205-215
12. Kiviranta R., Morko J., Alatalo S.L., Nicamhlaoibh R., Risteli J., Laitala-Leinonen T., et al. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. Bone 36 (2005) 159-172
13. Drake F.H., Dodds R.A., James I.E., Connor J.R., Debouck C., Richardson S., et al. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J. Biol. Chem. 271 (1996) 12511-12516
14. Rantakokko J., Aro H.T., Savontaus M., and Vuorio E. Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development. FEBS Lett. 393 (1996) 307-313
15. Littlewood-Evans A., Kokubo T., Ishibashi O., Inaoka T., Wlodarski B., Gallagher J.A., et al. Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone. 20 (1997) 81-86
16. Yamaza T., Goto T., Kamiya T., Kobayashi Y., Sakai H., and Tanaka T. Study of immunoelectron microscopic localization of cathepsin K in osteoclasts and other bone cells in the mouse femur. Bone 23 (1998) 499-509
17. Xia L., Kilb J., Wex H., Li Z., Lipyansky A., Breuil V., et al. Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones. Biol. Chem. 380 (1999) 679-687
18. Dodds R.A., James I.E., Rieman D., Ahern R., Hwang S.M., Connor J.R., Thompson S.D., Veber D.F., Drake F.H., Holmes S., et al. Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption. J. Bone Miner. Res. 16 (2001) 478-486
19. Rieman D.J., McClung H.A., Dodds R.A., Hwang S.M., Holmes M.W., James I.E., et al. Biosynthesis and processing of cathepsin K in cultured human osteoclasts. Bone 28 (2001) 282-289
20. Kollet O., Dar A., Shivtiel S., Kalinkovich A., Lapid K., Sztainberg Y., et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat. Med. 12 (2006) 657-664
21. Asagiri M., Hirai T., Kunigami T., Kamano S., Gober H.J., Okamoto K., et al. Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. Science 319 (2008) 624-627
22. Bossard M.J., Tomaszek T.A., Thompson S.K., Amegadzie B.Y., Hanning C.R., Jones C., et al. Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J. Biol. Chem. 271 (1996) 12517-12524
23. Garnero P., Borel O., Byrjalsen I., Ferreras M., Drake F.H., McQueney M.S., et al. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J. Biol. Chem. 273 (1998) 32347-32352
24. Gundberg C., Clough M., and Mort J. Proteolysis of human osteocalcin by MMP's and cathepsin K. J. Bone Miner. Res. 17 Suppl 1 (2002) S406 (abstract)
25. Vääräniemi J., Halleen J.M., Kaarlonen K., Ylipahkala H., Alatalo S.L., Andersson G., et al. Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J. Bone Miner. Res. 19 (2004) 1432-1440
26. Zenger S., Hollberg K., Ljusberg J., Norgård M., Ek-Rylander B., Kiviranta R., et al. Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice. Bone 41 (2007) 820-832
27. Rantakokko J., Uusitalo H., Jämsä T., Tuukkanen J., Aro H.T., and Vuorio E. Expression profiles of mRNAs for osteoblast and osteoclast proteins as indicators of bone loss in mouse immobilization osteopenia model. J. Bone Miner. Res. 14 (1999) 1934-1942
28. Furuyama N., and Fujisawa Y. Regulation of collagenolytic cysteine protease synthesis by estrogen in osteoclasts. Steroids 65 (2000) 371-378
29. Delaissé J.M., Eeckhout Y., and Vaes G. Inhibition of bone resorption in culture by inhibitors of thiol proteinases. Biochem. J. 192 (1980) 365-368
30. Inui T., Ishibashi O., Inaoka T., Origane Y., Kumegawa M., Kokubo T., et al. Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption. J. Biol. Chem. 272 (1997) 8109-8112
31. Votta B.J., Levy M.A., Badger A., Bradbeer J., Dodds R.A., James I.E., et al. Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. J. Bone Miner. Res. 12 (1997) 1396-1406
32. James I.E., Lark M.W., Zembryki D., Lee-Rykaczewski E.V., Hwang S.M., Tomaszek T.A., et al. Development and characterization of a human in vitro resorption assay: demonstration of utility using novel antiresorptive agents. J. Bone Miner. Res. 14 (1999) 1562-1569
33. Ishikawa T., Kamiyama M., Tani-Ishii N., Suzuki H., Ichikawa Y., Hamaguchi Y., et al. Inhibition of osteoclast differentiation and bone resorption by cathepsin K antisense oligonucleotides. Mol. Carcinog. 32 (2001) 84-91
34. Robichaud J., Oballa R., Prasit P., Falgueyret J.P., Percival M.D., Wesolowski G., et al. A novel class of nonpeptidic biaryl inhibitors of human cathepsin K. J. Med. Chem. 46 (2003) 3709-3727
35. Avnet S., Lamolinara A., Zini N., Solimando L., Quacquaruccio G., Granchi D., et al. Effects of antisense mediated inhibition of cathepsin K on human osteoclasts obtained from peripheral blood. J. Orthop. Res. 24 (2006) 1699-1708
36. Gelb B.D., Shi G.P., Chapman H.A., and Desnick R.J. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273 (1996) 1236-1238
37. Kiviranta R., Morko J., Uusitalo H., Aro H.T., Vuorio E., and Rantakokko J. Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K. J. Bone Miner. Res. 16 (2001) 1444-1452
38. Morko J., Kiviranta R., Hurme S., Rantakokko J., and Vuorio E. Differential turnover of cortical and trabecular bone in transgenic mice overexpressing cathepsin K. Bone 36 (2005) 854-865
39. Marjomäki V.S., Huovila A.P., Surkka M.A., Jokinen I., and Salminen A. Lysosomal trafficking in rat cardiac myocytes. J. Histochem. Cytochem. 38 (1990) 1155-1164
40. Alatalo S.L., Halleen J.M., Hentunen T.A., Mönkkönen J., and Väänänen H.K. Rapid screening method for osteoclast differentiation in vitro that measures tartrate-resistant acid phosphatase 5b activity secreted into the culture medium. Clin. Chem. 46 (2000) 1751-1754
41. Hellman J., Käkönen S.M., Matikainen M.T., Karp M., Lövgren T., Väänänen H.K., et al. Epitope mapping of nine monoclonal antibodies against osteocalcin: combinations into two-site assays affect both assay specificity and sample stability. J. Bone Miner. Res. 11 (1996) 1165-1175
42. Lakkakorpi P., Tuukkanen J., Hentunen T., Järvelin K., and Väänänen K. Organization of osteoclast microfilaments during the attachment to bone surface in vitro. J. Bone Miner. Res. 4 (1989) 817-825
43. Ivaska K.K., Hentunen T.A., Vääräniemi J., Ylipahkala H., Pettersson K., and Väänänen H.K. Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J. Biol. Chem. 279 (2004) 18361-18369
44. Palokangas H., Mulari M., and Väänänen H.K. Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts. J. Cell. Sci. 110 Pt 15 (1997) 1767-1780
45. Mulari M.T., Zhao H., Lakkakorpi P.T., and Väänänen H.K. Osteoclast ruffled border has distinct subdomains for secretion and degraded matrix uptake. Traffic 4 (2003) 113-125
46. Zerial M., Parton R., Chavrier P., and Frank R. Localization of Rab family members in animal cells. Methods Enzymol. 219 (1992) 398-407
47. Zhao H., Laitala-Leinonen T., Parikka V., and Väänänen H.K. Downregulation of small GTPase Rab7 impairs osteoclast polarization and bone resorption. J. Biol. Chem. 276 (2001) 39295-39302
48. Salo J. Bone resorbing osteoclasts reveal two basal plasma membrane domains and transcytosis of degraded matrix material. PhD thesis. Annales Universitatis Ouluensis (http://herkules.oulu.fi/isbn9514268296/) 2002.
49. Selander K., Lehenkari P., and Väänänen H.K. The effects of bisphosphonates on the resorption cycle of isolated osteoclasts. Calcif. Tissue Int. 55 (1994) 368-375
50. Sundström J., Pelliniemi L.J., Kuopio T., Veräjänkorva E., Fröjdman K., Harley V., et al. Characterization of the model for experimental testicular teratoma in 129/SvJ-mice. Br. J. Cancer 80 (1999) 149-160
51. Baron R., Neff L., Brown W., Courtoy P.J., Louvard D., and Farquhar M.G. Polarized secretion of lysosomal enzymes: co-distribution of cation-independent mannose-6-phosphate receptors and lysosomal enzymes along the osteoclast exocytic pathway. J. Cell Biol. 106 (1988) 1863-1872
52. Blair H.C., Teitelbaum S.L., Schimke P.A., Konsek J.D., Koziol C.M., and Schlesinger P.H. Receptor-mediated uptake of a mannose-6-phosphate bearing glycoprotein by isolated chicken osteoclasts. J. Cell. Physiol. 137 (1988) 476-482
53. Baron R., Neff L., Brown W., Louvard D., and Courtoy P.J. Selective internalization of the apical plasma membrane and rapid redistribution of lysosomal enzymes and mannose 6-phosphate receptors during osteoclast inactivation by calcitonin. J. Cell. Sci. 97 Pt 3 (1990) 439-447
54. Zhao H., Ettala O., and Väänänen H.K. Intracellular membrane trafficking pathways in bone-resorbing osteoclasts revealed by cloning and subcellular localization studies of small GTP-binding rab proteins. Biochem. Biophys. Res. Commun. 293 (2002) 1060-1065
55. Barbero P., Bittova L., and Pfeffer S.R. Visualization of Rab9-mediated vesicle transport from endosomes to the trans-Golgi in living cells. J. Cell Biol. 156 (2002) 511-518
56. Parikka V., Lehenkari P., Sassi M.L., Halleen J., Risteli J., Härkönen P., and Väänänen H.K. Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts. Endocrinol 142 (2001) 5371-5378
57. Brage M., Lie A., Ransjö M., Kasprzykowski F., Kasprzykowska R., Abrahamson M., Grubb A., Lerner U.H., et al. Osteoclastogenesis is decreased by cysteine proteinase inhibitors. Bone 34 (2001) 412-424
58. Frattini A., Pangarazio A., Susani L., Sobacchi C., Mirolo M., Abinun M., et al. Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J. Bone Miner. Res. 18 (2003) 1740-1747
59. Bucay N., Sarosi I., Dunstan C.R., Morony S., Tarpley J., Capparelli C., et al. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12 (1998) 1260-1268
60. Mizuno A., Amizuka N., Irie K., Murakami A., Fujise N., Kanno T., et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem. Biophys. Res. Commun. 247 (1998) 610-615
61. Mizuno A., Kanno T., Hoshi M., Shibata O., Yano K., Fujise N., et al. Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis. J. Bone Miner. Metab. 20 (2002) 337-344
62. Nesbitt S.A., and Horton M.A. Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 276 (1997) 266-269
63. Salo J., Lehenkari P., Mulari M., Metsikkö K., and Väänänen H.K. Removal of osteoclast bone resorption products by transcytosis. Science 276 (1997) 270-273
64. McQueney M.S., Amegadzie B.Y., D'Alessio K., Hanning C.R., McLaughlin M.M., McNulty D., et al. Autocatalytic activation of human cathepsin K. J. Biol. Chem. 272 (1997) 13955-13960
65. Clark S.A., Ambrose W.W., Anderson T.R., Terrell R.S., and Toverud S.U. Ultrastructural localization of tartrate-resistant, purple acid phosphatase in rat osteoclasts by histochemistry and immunocytochemistry. J. Bone Miner. Res. 4 (1989) 399-405
66. Reinholt F.P., Widholm S.M., Ek-Rylander B., and Andersson G. Ultrastructural localization of a tartrate-resistant acid ATPase in bone. J. Bone Miner. Res. 5 (1990) 1055-1061
67. Halleen J.M., Räisänen S., Salo J.J., Reddy S.V., Roodman G.D., Hentunen T.A., et al. Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J. Biol. Chem. 274 (1999) 22907-22910
68. Hollberg K., Hultenby K., Hayman A., Cox T., and Andersson G. Osteoclasts from mice deficient in tartrate-resistant acid phosphatase have altered ruffled borders and disturbed intracellular vesicular transport. Exp. Cell Res. 279 (2002) 227-238
69. Everts V., Korper W., Jansen D.C., Steinfort J., Lammerse I., Heera S., et al. Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J. 13 (1999) 1219-1230
70. Shorey S., Heersche J.N., and Manolson M.F. The relative contribution of cysteine proteinases and matrix metalloproteinases to the resorption process in osteoclasts derived from long bone and scapula. Bone 35 (2004) 909-917
71. Ilvesaro J.M., Lakkakorpi P.T., and Väänänen H.K. Inhibition of bone resorption in vitro by a peptide containing the cadherin cell adhesion recognition sequence HAV is due to prevention of sealing zone formation. Exp. Cell Res. 242 (1998) 75-83
72. Ilvesaro J., Väänänen K., and Tuukkanen J. Bone-resorbing osteoclasts contain gap-junctional connexin-43. J. Bone Miner. Res. 15 (2000) 919-926
73. Everts V., Delaisse J.M., Korper W., Jansen D.C., Tigchelaar-Gutter W., Saftig P., et al. The bone lining cell: its role in cleaning Howship's lacunae and initiating bone formation. J. Bone Miner. Res. 17 (2002) 77-90
74. Mulari M.t., Qu Q., Härkönen P.L., and Väänänen H.k. Osteoblast-like cells complete osteoclastic bone resorption and form new mineralized bone matrix in vitro. Calcif. Tissue Int. 75 (2004) 253-261
75. Parikka V., Väänänen A., Risteli J., Salo T., Sorsa T., Väänänen H.K., et al. Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases. Matrix. Biol. 24 (2005) 438-447
76. Azuma Y., Kaji K., Katogi R., Takeshita S., and Kudo A. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J. Biol. Chem. 275 (2000) 4858-4864
77. Hou W.S., Li W., Keyszer G., Weber E., Levy R., Klein M.J., et al. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium. Arthritis Rheum. 46 (2002) 663-674
78. Jimi E., Akiyama S., Tsurukai T., Okahashi N., Kobayashi K., Udagawa N., et al. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J. Immunol. 163 (1999) 434-442
79. Jimi E., Nakamura I., Duong L.T., Ikebe T., Takahashi N., Rodan G.A., et al. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp. Cell Res. 247 (1999) 84-93
80. Kobayashi K., Takahashi N., Jimi E., Udagawa N., Takami M., Kotake S., et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191 (2000) 275-286
81. Centrella M., McCarthy T.L., and Canalis E. Tumor necrosis factor-α inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures. Endocrinology 123 (1988) 1442-1448
82. Gilbert L., He X., Farmer P., Boden S., Kozlowski M., Rubin J., et al. Inhibition of osteoblast differentiation by tumor necrosis factor-. Endocrinol 141 (2000) 3956-3964
83. Nakashima T., and Takayanagi H. The dynamic interplay between osteoclasts and the immune system. Arch. Biochem. Biophys. 473 (2008) 166-171
84. Walsh M.C., and Choi Y. Biology of the TRANCE axis. Cytokine Growth Factor Rev. 14 (2003) 251-263
85. Lubberts E., van den Bersselaar L., Oppers-Walgreen B., Schwarzenberger P., Coenen-de Roo C.J., Kolls J.K., et al. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J. Immunol. 170 (2003) 2562-2655
86. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203 (2006) 282-2673
87. Zenger S., Hollberg K., Ljusberg J., Norgård M., Ek-rylander B., Kiviranta R., et al. Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice. Bone 41 (2007) 820-832
88. Lee N.K., Choi Y.G., Baik J.Y., Han S.Y., Jeong D.W., Bae Y.S., et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106 (2005) 852-859
89. 2+ and an oxidant signal. Cell 121 (2005) 281-293